| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 151, 1105-1113, Copyright © 1997 by American Society for Investigative Pathology
REGULAR ARTICLES |
M Luca, S Huang, JE Gershenwald, RK Singh, R Reich and M Bar-Eli
Department of Cell Biology, University of Texas M. D. Anderson Cancer Center, Houston 77030, USA.
Expression of interleukin-8 (IL-8) by human melanoma cells correlates with their metastatic potential. Moreover, UV-B irradiation of primary cutaneous melanoma cells induces IL-8 mRNA and protein production and increases both tumor growth and metastasis in nude mice. Although IL-8 has been shown to be an angiogenic factor, the biological consequences of increased IL-8 production by melanoma cells and the role of IL-8 in the metastatic process remains unclear. The purpose of this study was to determine the role of IL-8 in tumor growth and metastasis of human melanoma cells. Nonmetastatic SB-2 melanoma cells with negligible levels of IL-8 were transfected with IL-8 cDNA and subsequently analyzed for changes in their tumorigenic and metastatic potential. Enforced expression of IL-8 rendered the melanoma cells highly tumorigenic and increased their metastatic potential as compared with parental and control transfected cells. The IL-8-transfected cells displayed up-regulation in M(r) 72,000 collagenase type IV (MMP-2) mRNA and collagenase activity and increased invasiveness through Matrigel- coated filters. Moreover, when the MMP-2 promoter was linked upstream of the chloramphenicol acetyltransferase (CAT) reporter gene, CAT activity was up-regulated in IL-8 but not in control transfected cells, suggesting that IL-8 is involved in MMP-2 gene transcription. Activation of type IV collagenase by IL-8 can enhance the invasion of host stroma by the tumor cells and increase angiogenesis and, hence, metastasis.
This article has been cited by other articles:
![]() |
M. Hsu, S.-Y. Wu, S.-S. Chang, I.-J. Su, C.-H. Tsai, S.-J. Lai, A.-L. Shiau, K. Takada, and Y. Chang Epstein-Barr Virus Lytic Transactivator Zta Enhances Chemotactic Activity through Induction of Interleukin-8 in Nasopharyngeal Carcinoma Cells J. Virol., April 1, 2008; 82(7): 3679 - 3688. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. M. Merritt, Y. G. Lin, W. A. Spannuth, M. S. Fletcher, A. A. Kamat, L. Y. Han, C. N. Landen, N. Jennings, K. De Geest, R. R. Langley, et al. Effect of Interleukin-8 Gene Silencing With Liposome-Encapsulated Small Interfering RNA on Ovarian Cancer Cell Growth J Natl Cancer Inst, March 5, 2008; 100(5): 359 - 372. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Geraghty, M. P. Rogan, C. M. Greene, R. M. M. Boxio, T. Poiriert, M. O'Mahony, A. Belaaouaj, S. J. O'Neill, C. C. Taggart, and N. G. McElvaney Neutrophil Elastase Up-Regulates Cathepsin B and Matrix Metalloprotease-2 Expression J. Immunol., May 1, 2007; 178(9): 5871 - 5878. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Dell'Eva, C. Ambrosini, S. Minghelli, D. M. Noonan, A. Albini, and N. Ferrari The Akt inhibitor deguelin, is an angiopreventive agent also acting on the NF-{kappa}B pathway Carcinogenesis, February 1, 2007; 28(2): 404 - 413. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Bu, L. Gao, J. Zhuang, J. Feng, D. Yang, and X. Yan Anti-CD146 monoclonal antibody AA98 inhibits angiogenesis via suppression of nuclear factor-{kappa}B activation. Mol. Cancer Ther., November 1, 2006; 5(11): 2872 - 2878. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-M. Park, M.-J. Park, H.-J. Kwak, H.-C. Lee, M.-S. Kim, S.-H. Lee, I.-C. Park, C. H. Rhee, and S.-I. Hong Ionizing Radiation Enhances Matrix Metalloproteinase-2 Secretion and Invasion of Glioma Cells through Src/Epidermal Growth Factor Receptor-Mediated p38/Akt and Phosphatidylinositol 3-Kinase/Akt Signaling Pathways. Cancer Res., September 1, 2006; 66(17): 8511 - 8519. [Abstract] [Full Text] [PDF] |
||||
![]() |
B.-Y. Bao, J. Yao, and Y.-F. Lee 1{alpha}, 25-dihydroxyvitamin D3 suppresses interleukin-8-mediated prostate cancer cell angiogenesis Carcinogenesis, September 1, 2006; 27(9): 1883 - 1893. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Liu and A. Deisseroth Tumor vascular targeting therapy with viral vectors Blood, April 15, 2006; 107(8): 3027 - 3033. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Cortez, C. A. Lyman, S. Kottilil, H. S. Kim, E. Roilides, J. Yang, B. Fullmer, R. Lempicki, and T. J. Walsh Functional Genomics of Innate Host Defense Molecules in Normal Human Monocytes in Response to Aspergillus fumigatus Infect. Immun., April 1, 2006; 74(4): 2353 - 2365. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Lu, W. Ouyang, and C. Huang Inflammation, a Key Event in Cancer Development Mol. Cancer Res., April 1, 2006; 4(4): 221 - 233. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Kollmar, C. Scheuer, M. D. Menger, and M. K. Schilling Macrophage Inflammatory Protein-2 Promotes Angiogenesis, Cell Migration, and Tumor Growth in Hepatic Metastasis Ann. Surg. Oncol., February 1, 2006; 13(2): 263 - 275. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Kubo, S. Ueno, K. Hiwatashi, M. Sakoda, K. Kawaida, K. Nuruki, and T. Aikou Interleukin 8 in Human Hepatocellular Carcinoma Correlates With Cancer Cell Invasion of Vessels But Not With Tumor Angiogenesis Ann. Surg. Oncol., October 1, 2005; 12(10): 800 - 807. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-W. Kim, M. Hayashi, J.-F. Lo, C. Fearns, R. Xiang, G. Lazennec, Y. Yang, and J.-D. Lee Tid1 Negatively Regulates the Migratory Potential of Cancer Cells by Inhibiting the Production of Interleukin-8 Cancer Res., October 1, 2005; 65(19): 8784 - 8791. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Milyavsky, Y. Tabach, I. Shats, N. Erez, Y. Cohen, X. Tang, M. Kalis, I. Kogan, Y. Buganim, N. Goldfinger, et al. Transcriptional Programs following Genetic Alterations in p53, INK4A, and H-Ras Genes along Defined Stages of Malignant Transformation Cancer Res., June 1, 2005; 65(11): 4530 - 4543. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Christensen, P. W. Vincent, W. D. Klohs, D. W. Fry, W. R. Leopold, and W. L. Elliott Plasma vascular endothelial growth factor and interleukin-8 as biomarkers of antitumor efficacy of a prototypical erbB family tyrosine kinase inhibitor Mol. Cancer Ther., June 1, 2005; 4(6): 938 - 947. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J.W. Chen, Y.-C. Lin, P.-L. Yao, A. Yuan, H.-Y. Chen, C.-T. Shun, M.-F. Tsai, C.-H. Chen, and P.-C. Yang Tumor-Associated Macrophages: The Double-Edged Sword in Cancer Progression J. Clin. Oncol., February 10, 2005; 23(5): 953 - 964. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Bales, L. Mills, N. Milam, M. McGahren-Murray, D. Bandyopadhyay, D. Chen, J. A. Reed, N. Timchenko, J. J. van den Oord, M. Bar-Eli, et al. The Low Molecular Weight Cyclin E Isoforms Augment Angiogenesis and Metastasis of Human Melanoma Cells In vivo Cancer Res., February 1, 2005; 65(3): 692 - 697. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Sato, N. Maehara, and M. Goggins Gene Expression Profiling of Tumor-Stromal Interactions between Pancreatic Cancer Cells and Stromal Fibroblasts Cancer Res., October 1, 2004; 64(19): 6950 - 6956. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. De Larco, B. R. K. Wuertz, and L. T. Furcht The Potential Role of Neutrophils in Promoting the Metastatic Phenotype of Tumors Releasing Interleukin-8 Clin. Cancer Res., August 1, 2004; 10(15): 4895 - 4900. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Murphy, C. M. Villano, R. Dorn, and L. A. White Interaction between the Aryl Hydrocarbon Receptor and Retinoic Acid Pathways Increases Matrix Metalloproteinase-1 Expression in Keratinocytes J. Biol. Chem., June 11, 2004; 279(24): 25284 - 25293. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. Lev, A. Onn, V. O. Melinkova, C. Miller, V. Stone, M. Ruiz, E. C. McGary, H. N. Ananthaswamy, J. E. Price, and M. Bar-Eli Exposure of Melanoma Cells to Dacarbazine Results in Enhanced Tumor Growth and Metastasis In Vivo J. Clin. Oncol., June 1, 2004; 22(11): 2092 - 2100. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Zhang, M. Bar-Eli, S. Meloche, and P. Brodt Dual Regulation of MMP-2 Expression by the Type 1 Insulin-like Growth Factor Receptor: THE PHOSPHATIDYLINOSITOL 3-KINASE/Akt AND Raf/ERK PATHWAYS TRANSMIT OPPOSING SIGNALS J. Biol. Chem., May 7, 2004; 279(19): 19683 - 19690. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Takeuchi, A. Fujimoto, M. Tanaka, T. Yamano, E. Hsueh, and D. S. B. Hoon CCL21 Chemokine Regulates Chemokine Receptor CCR7 Bearing Malignant Melanoma Cells Clin. Cancer Res., April 1, 2004; 10(7): 2351 - 2358. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Xu, P. S. Pathak, and D. Fukumura Hypoxia-Induced Activation of p38 Mitogen-Activated Protein Kinase and Phosphatidylinositol 3'-Kinase Signaling Pathways Contributes to Expression of Interleukin 8 in Human Ovarian Carcinoma Cells Clin. Cancer Res., January 15, 2004; 10(2): 701 - 707. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Ren, R. T.-P. Poon, H.-T. Tsui, W.-H. Chen, Z. Li, C. Lau, W.-C. Yu, and S.-T. Fan Interleukin-8 Serum Levels in Patients with Hepatocellular Carcinoma: Correlations with Clinicopathological Features and Prognosis Clin. Cancer Res., December 1, 2003; 9(16): 5996 - 6001. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. De Larco, B. R. K. Wuertz, D. Yee, B. L. Rickert, and L. T. Furcht Atypical methylation of the interleukin-8 gene correlates strongly with the metastatic potential of breast carcinoma cells PNAS, November 25, 2003; 100(24): 13988 - 13993. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kunz, S. Moeller, D. Koczan, P. Lorenz, R. H. Wenger, M. O. Glocker, H.-J. Thiesen, G. Gross, and S. M. Ibrahim Mechanisms of Hypoxic Gene Regulation of Angiogenesis Factor Cyr61 in Melanoma Cells J. Biol. Chem., November 14, 2003; 278(46): 45651 - 45660. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. Lev, M. Ruiz, L. Mills, E. C. McGary, J. E. Price, and M. Bar-Eli Dacarbazine Causes Transcriptional Up-Regulation of Interleukin 8 and Vascular Endothelial Growth Factor in Melanoma Cells: A Possible Escape Mechanism from Chemotherapy Mol. Cancer Ther., August 1, 2003; 2(8): 753 - 763. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. M. Mian, C. P. N. Dinney, C. E. Bermejo, P. Sweeney, C. Tellez, X. D. Yang, J. M. Gudas, D. J. McConkey, and M. Bar-Eli Fully Human Anti-Interleukin 8 Antibody Inhibits Tumor Growth in Orthotopic Bladder Cancer Xenografts via Down-Regulation of Matrix Metalloproteases and Nuclear Factor-{kappa}B Clin. Cancer Res., August 1, 2003; 9(8): 3167 - 3175. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Levine, J. A. Lucci III, B. Pazdrak, J.-Z. Cheng, Y.-S. Guo, C. M. Townsend Jr., and M. R. Hellmich Bombesin Stimulates Nuclear Factor {kappa}B Activation and Expression of Proangiogenic Factors in Prostate Cancer Cells Cancer Res., July 1, 2003; 63(13): 3495 - 3502. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Karashima, P. Sweeney, A. Kamat, S. Huang, S. J. Kim, M. Bar-Eli, D. J. McConkey, and C. P. N. Dinney Nuclear Factor-{kappa}B Mediates Angiogenesis and Metastasis of Human Bladder Cancer through the Regulation of Interleukin-8 Clin. Cancer Res., July 1, 2003; 9(7): 2786 - 2797. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Li, S. Dubey, M. L. Varney, B. J. Dave, and R. K. Singh IL-8 Directly Enhanced Endothelial Cell Survival, Proliferation, and Matrix Metalloproteinases Production and Regulated Angiogenesis J. Immunol., March 15, 2003; 170(6): 3369 - 3376. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Watari, H. Watari, T. Fujimoto, H. Yamada, J. Nishihira, J. f. Strauss III, and S. Fujimoto Lipopolysaccharide Induces Interleukin-8 Production By Human Cervical Smooth Muscle Cells Reproductive Sciences, February 1, 2003; 10(2): 110 - 117. [Abstract] [PDF] |
||||
![]() |
J. J.W. Chen, P.-L. Yao, A. Yuan, T.-M. Hong, C.-T. Shun, M.-L. Kuo, Y.-C. Lee, and P.-C. Yang Up-Regulation of Tumor Interleukin-8 Expression by Infiltrating Macrophages: Its Correlation with Tumor Angiogenesis and Patient Survival in Non-Small Cell Lung Cancer Clin. Cancer Res., February 1, 2003; 9(2): 729 - 737. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Di Girolamo, R. K. Kumar, M. T. Coroneo, and D. Wakefield UVB-Mediated Induction of Interleukin-6 and -8 in Pterygia and Cultured Human Pterygium Epithelial Cells Invest. Ophthalmol. Vis. Sci., November 1, 2002; 43(11): 3430 - 3437. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Levy, C. Neuveut, C.-A. Renard, P. Charneau, S. Branchereau, F. Gauthier, J. T. Van Nhieu, D. Cherqui, A.-F. Petit-Bertron, D. Mathieu, et al. Transcriptional Activation of Interleukin-8 by beta -Catenin-Tcf4 J. Biol. Chem., October 25, 2002; 277(44): 42386 - 42393. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. K. L. Woodward, S. R. Elshaw, A. K. Murray, C. E. Nichols, N. Cross, D. Laws, I. G. Rennie, and K. Sisley Stimulation and Inhibition of Uveal Melanoma Invasion by HGF, GRO, IL-1{alpha} and TGF-{beta} Invest. Ophthalmol. Vis. Sci., October 1, 2002; 43(10): 3144 - 3152. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. A. Scappaticci Mechanisms and Future Directions for Angiogenesis-Based Cancer Therapies J. Clin. Oncol., September 15, 2002; 20(18): 3906 - 3927. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Mills, C. Tellez, S. Huang, C. Baker, M. McCarty, L. Green, J. M. Gudas, X. Feng, and M. Bar-Eli Fully Human Antibodies to MCAM/MUC18 Inhibit Tumor Growth and Metastasis of Human Melanoma Cancer Res., September 1, 2002; 62(17): 5106 - 5114. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Salcedo, M. Martins-Green, B. Gertz, J. J. Oppenheim, and W. J. Murphy Combined Administration of Antibodies to Human Interleukin 8 and Epidermal Growth Factor Receptor Results in Increased Antimetastatic Effects on Human Breast Carcinoma Xenografts Clin. Cancer Res., August 1, 2002; 8(8): 2655 - 2665. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Huang, L. Mills, B. Mian, C. Tellez, M. McCarty, X.-D. Yang, J. M. Gudas, and M. Bar-Eli Fully Humanized Neutralizing Antibodies to Interleukin-8 (ABX-IL8) Inhibit Angiogenesis, Tumor Growth, and Metastasis of Human Melanoma Am. J. Pathol., July 1, 2002; 161(1): 125 - 134. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Fujimoto, I. Aoki, S. Khatun, H. Toyoki, and T. Tamaya Clinical implications of expression of interleukin-8 related to myometrial invasion with angiogenesis in uterine endometrial cancers Ann. Onc., March 1, 2002; 13(3): 430 - 434. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Straume and L. A. Akslen Importance of Vascular Phenotype by Basic Fibroblast Growth Factor, and Influence of the Angiogenic Factors Basic Fibroblast Growth Factor/Fibroblast Growth Factor Receptor-1 and Ephrin-A1/EphA2 on Melanoma Progression Am. J. Pathol., March 1, 2002; 160(3): 1009 - 1019. [Abstract] [Full Text] [PDF] |
||||
![]() |
C Cuello, D Wakefield, and N Di Girolamo Neutrophil accumulation correlates with type IV collagenase/gelatinase activity in endotoxin induced uveitis Br. J. Ophthalmol., March 1, 2002; 86(3): 290 - 295. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Yuan, C.-J. Yu, K.-T. Luh, S.-H. Kuo, Y.-C. Lee, and P.-C. Yang Aberrant p53 Expression Correlates With Expression of Vascular Endothelial Growth Factor mRNA and Interleukin-8 mRNA and Neoangiogenesis in Non-Small-Cell Lung Cancer J. Clin. Oncol., February 15, 2002; 20(4): 900 - 910. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Satyamoorthy, G. Li, B. Vaidya, J. Kalabis, and M. Herlyn Insulin-like Growth Factor-I-induced Migration of Melanoma Cells Is Mediated by Interleukin-8 Induction Cell Growth Differ., February 1, 2002; 13(2): 87 - 93. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. S. Shapiro, M. N. Mollenauer, and A. Weiss Endogenous CD28 expressed on myeloma cells up-regulates interleukin-8 production: implications for multiple myeloma progression Blood, July 1, 2001; 98(1): 187 - 193. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Wolf, Z. Chen, G. Dong, J. B. Sunwoo, C. C. Bancroft, D. E. Capo, N. T. Yeh, N. Mukaida, and C. V. Waes IL (Interleukin)-1{{alpha}} Promotes Nuclear Factor-{{kappa}}B and AP-1-induced IL-8 Expression, Cell Survival, and Proliferation in Head and Neck Squamous Cell Carcinomas Clin. Cancer Res., June 1, 2001; 7(6): 1812 - 1820. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. De Larco, B. R. K. Wuertz, J. C. Manivel, and L. T. Furcht Progression and Enhancement of Metastatic Potential after Exposure of Tumor Cells to Chemotherapeutic Agents Cancer Res., April 1, 2001; 61(7): 2857 - 2861. [Abstract] [Full Text] |
||||
![]() |
B. Davidson, R. Reich, I. Goldberg, W. H. Gotlieb, J. Kopolovic, A. Berner, G. Ben-Baruch, M. Bryne, and J. M. Nesland Ets-1 Messenger RNA Expression Is a Novel Marker of Poor Survival in Ovarian Carcinoma Clin. Cancer Res., March 1, 2001; 7(3): 551 - 557. [Abstract] [Full Text] |
||||
![]() |
J. E. De Larco, B. R. K. Wuertz, K. A. Rosner, S. A. Erickson, D. E. Gamache, J. C. Manivel, and L. T. Furcht A Potential Role for Interleukin-8 in the Metastatic Phenotype of Breast Carcinoma Cells Am. J. Pathol., February 1, 2001; 158(2): 639 - 646. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. YUAN, P.-C. YANG, C.-J. YU, W.-J. CHEN, F.-Y. LIN, S.-H. KUO, and K.-T. LUH Interleukin-8 Messenger Ribonucleic Acid Expression Correlates with Tumor Progression, Tumor Angiogenesis, Patient Survival, and Timing of Relapse in Non-Small-Cell Lung Cancer Am. J. Respir. Crit. Care Med., November 1, 2000; 162(5): 1957 - 1963. [Abstract] [Full Text] |
||||
![]() |
R. SALCEDO, J. H. RESAU, D. HALVERSON, E. A. HUDSON, M. DAMBACH, D. POWELL, K. WASSERMAN, and J. J. OPPENHEIM Differential expression and responsiveness of chemokine receptors (CXCR1-3) by human microvascular endothelial cells and umbilical vein endothelial cells FASEB J, October 1, 2000; 14(13): 2055 - 2064. [Abstract] [Full Text] |
||||
![]() |
E. K. Rofstad and E. F. Halsør Vascular Endothelial Growth Factor, Interleukin 8, Platelet-derived Endothelial Cell Growth Factor, and Basic Fibroblast Growth Factor Promote Angiogenesis and Metastasis in Human Melanoma Xenografts Cancer Res., September 1, 2000; 60(17): 4932 - 4938. [Abstract] [Full Text] |
||||
![]() |
Y. Kitadai, K. Haruma, N. Mukaida, Y. Ohmoto, N. Matsutani, W. Yasui, S. Yamamoto, K. Sumii, G. Kajiyama, I. J. Fidler, et al. Regulation of Disease-Progression Genes in Human Gastric Carcinoma Cells by Interleukin 8 Clin. Cancer Res., July 1, 2000; 6(7): 2735 - 2740. [Abstract] [Full Text] |
||||
![]() |
S. Huang, A. DeGuzman, C. D. Bucana, and I. J. Fidler Nuclear Factor-{{kappa}}B Activity Correlates with Growth, Angiogenesis, and Metastasis of Human Melanoma Cells in Nude Mice Clin. Cancer Res., June 1, 2000; 6(6): 2573 - 2581. [Abstract] [Full Text] |
||||
![]() |
M. J. Frederick, Y. Henderson, X. Xu, M. T. Deavers, A. A. Sahin, H. Wu, D. E. Lewis, A. K. El-Naggar, and G. L. Clayman In Vivo Expression of the Novel CXC Chemokine BRAK in Normal and Cancerous Human Tissue Am. J. Pathol., June 1, 2000; 156(6): 1937 - 1950. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Fujimoto, H. Sakaguchi, I. Aoki, and T. Tamaya Clinical Implications of Expression of Interleukin 8 Related to Angiogenesis in Uterine Cervical Cancers Cancer Res., May 1, 2000; 60(10): 2632 - 2635. [Abstract] [Full Text] |
||||
![]() |
K. Inoue, J. W. Slaton, B. Y. Eve, S. J. Kim, P. Perrotte, M. D. Balbay, S. Yano, M. Bar-Eli, R. Radinsky, C. A. Pettaway, et al. Interleukin 8 Expression Regulates Tumorigenicity and Metastases in Androgen-independent Prostate Cancer Clin. Cancer Res., May 1, 2000; 6(5): 2104 - 2119. [Abstract] [Full Text] |
||||
![]() |
K. Inoue, J. W. Slaton, S. J. Kim, P. Perrotte, B. Y. Eve, M. Bar-Eli, R. Radinsky, and C. P. N. Dinney Interleukin 8 Expression Regulates Tumorigenicity and Metastasis in Human Bladder Cancer Cancer Res., April 1, 2000; 60(8): 2290 - 2299. [Abstract] [Full Text] |
||||
![]() |
S. Kim, K. Bell, S. A. Mousa, and J. A. Varner Regulation of Angiogenesis in Vivo by Ligation of Integrin {alpha}5{beta}1 with the Central Cell-Binding Domain of Fibronectin Am. J. Pathol., April 1, 2000; 156(4): 1345 - 1362. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. C. Anderson, S. E. Mari, R. J. Broderick, B. P. Mari, and M. A. Shipp The Angiogenic Factor Interleukin 8 Is Induced in Non-Small Cell Lung Cancer/Pulmonary Fibroblast Cocultures Cancer Res., January 1, 2000; 60(2): 269 - 272. [Abstract] [Full Text] |
||||